{"status":"ok","message-type":"work-list","message-version":"1.0.0","message":{"facets":{},"total-results":4533897,"items":[{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T01:07:17Z","timestamp":1760404037974,"version":"build-2065373602"},"reference-count":0,"publisher":"Oxford University PressNew York, NY","isbn-type":[{"type":"print","value":"9780192626523"},{"type":"electronic","value":"9781383000948"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[1995,12,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In this chapter we outline the drug treatment of a variety of conditions which the general psychiatrist may be called on to treat or about which his advice may be sought. He may be asked to treat the psychiatric complications of a neurological or general medical condition, or encounter a medical or surgical patient with psychiatric co-morbidity. The many interfaces between psychiatry and neurology, internal medicine, and clinical psychology are moving rapidly and the psychiatnst has to be proficient in adjusting his role, and be aware of changing technologies, practices and views in other specialties, so that his advice is feasible and compatible with other management strategies.<\/jats:p>","DOI":"10.1093\/oso\/9780192626523.003.0017","type":"book-chapter","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T17:10:08Z","timestamp":1698772208000},"page":"373-391","source":"Crossref","is-referenced-by-count":0,"title":["Miscellaneous disorders and drugs"],"prefix":"10.1093","author":[{"given":"Malcolm","family":"Lader","sequence":"first","affiliation":[]},{"given":"Reginald","family":"Herrington","sequence":"additional","affiliation":[]}],"member":"286","container-title":["Biological Treatments in Psychiatry"],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/book\/chapter-pdf\/52138581\/isbn-9780192626523-book-part-17.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T22:57:09Z","timestamp":1760396229000},"score":20.507439,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/book\/52002\/chapter\/420938835"}},"issued":{"date-parts":[[1995,12,14]]},"ISBN":["9780192626523","9781383000948"],"references-count":0,"URL":"https:\/\/doi.org\/10.1093\/oso\/9780192626523.003.0017","published":{"date-parts":[[1995,12,14]]}},{"indexed":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T06:02:33Z","timestamp":1744005753006},"reference-count":0,"publisher":"Elsevier","isbn-type":[{"value":"9780721605586","type":"print"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2007]]},"DOI":"10.1016\/b978-072160558-6.50018-6","type":"book-chapter","created":{"date-parts":[[2009,5,15]],"date-time":"2009-05-15T11:17:47Z","timestamp":1242386267000},"page":"275-290","source":"Crossref","is-referenced-by-count":2,"title":["Miscellaneous Treatments for Solid Tumors"],"prefix":"10.1016","author":[{"given":"S","family":"WITHROW","sequence":"first","affiliation":[]}],"member":"78","container-title":["Withrow &amp; MacEwen's Small Animal Clinical Oncology"],"language":"en","deposited":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T13:26:58Z","timestamp":1545226018000},"score":19.911587,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780721605586500186"}},"issued":{"date-parts":[[2007]]},"ISBN":["9780721605586"],"references-count":0,"URL":"https:\/\/doi.org\/10.1016\/b978-072160558-6.50018-6","published":{"date-parts":[[2007]]}},{"indexed":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T14:52:00Z","timestamp":1714402320035},"edition-number":"1","reference-count":0,"publisher":"Wiley","isbn-type":[{"value":"9781405178228","type":"print"},{"value":"9781444300673","type":"electronic"}],"license":[{"start":{"date-parts":[[2008,10,24]],"date-time":"2008-10-24T00:00:00Z","timestamp":1224806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2008,10,24]]},"DOI":"10.1002\/9781444300673.ch17","type":"other","created":{"date-parts":[[2010,4,30]],"date-time":"2010-04-30T16:46:43Z","timestamp":1272646003000},"page":"206-213","source":"Crossref","is-referenced-by-count":1,"title":["Other Miscellaneous Treatments"],"prefix":"10.1002","author":[{"given":"Christopher","family":"Chen","sequence":"first","affiliation":[]},{"given":"Jinghao","family":"Han","sequence":"additional","affiliation":[]},{"given":"K. S. Lawrence","family":"Wong","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2009,2,12]]},"container-title":["Intracranial Atherosclerosis"],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/9781444300673.ch17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T01:55:25Z","timestamp":1692755725000},"score":19.003662,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/9781444300673.ch17"}},"issued":{"date-parts":[[2008,10,24]]},"ISBN":["9781405178228","9781444300673"],"references-count":0,"alternative-id":["10.1002\/9781444300673.ch17","10.1002\/9781444300673"],"URL":"https:\/\/doi.org\/10.1002\/9781444300673.ch17","archive":["Portico"],"published":{"date-parts":[[2008,10,24]]}},{"indexed":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T02:30:11Z","timestamp":1714357811424},"publisher-location":"UK","edition-number":"1","reference-count":0,"publisher":"CABI","isbn-type":[{"value":"9781845933432","type":"print"},{"value":"9781845933449","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1079\/9781845933432.0197","type":"book-chapter","created":{"date-parts":[[2009,11,16]],"date-time":"2009-11-16T18:23:31Z","timestamp":1258395811000},"page":"197-201","source":"Crossref","is-referenced-by-count":0,"title":["Miscellaneous phytosanitary treatments."],"prefix":"10.1079","author":[{"given":"N. W.","family":"Heather","sequence":"first","affiliation":[{"name":"Department of EntomologyNorth Carolina State UniversityRaleighNorth CarolinaUSA"}]},{"given":"G. J.","family":"Hallman","sequence":"additional","affiliation":[]}],"member":"242","published-online":{"date-parts":[[2008,1,14]]},"container-title":["Pest management and phytosanitary trade barriers"],"language":"en","deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T19:13:40Z","timestamp":1692213220000},"score":18.89635,"resource":{"primary":{"URL":"http:\/\/www.cabidigitallibrary.org\/doi\/10.1079\/9781845933432.0197"}},"issued":{"date-parts":[[2008,1]]},"ISBN":["9781845933432","9781845933449"],"references-count":0,"alternative-id":["10.1079\/9781845933432.0197","10.1079\/9781845933432.0000"],"URL":"https:\/\/doi.org\/10.1079\/9781845933432.0197","published":{"date-parts":[[2008,1]]}},{"indexed":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T05:33:54Z","timestamp":1732340034227,"version":"3.28.0"},"publisher-location":"Stuttgart","reference-count":0,"publisher":"Georg Thieme Verlag","isbn-type":[{"type":"print","value":"9781604064216"},{"type":"electronic","value":"9781604064223"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2012]]},"DOI":"10.1055\/b-0034-81934","type":"book-chapter","created":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T22:50:31Z","timestamp":1403736631000},"source":"Crossref","is-referenced-by-count":0,"title":["\u2666 Miscellaneous Disorders of the Pituitary Gland"],"prefix":"10.1055","member":"194","container-title":["Sellar and Parasellar Tumors"],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ebooks\/pdf\/10.1055\/b-0034-81934.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T14:57:16Z","timestamp":1732287436000},"score":18.441345,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/b-0034-81934"}},"editor":[{"given":"Edward R.","family":"Laws Jr.","sequence":"additional","affiliation":[]},{"given":"Jason P.","family":"Sheehan","sequence":"additional","affiliation":[]}],"issued":{"date-parts":[[2012]]},"ISBN":["9781604064216","9781604064223"],"references-count":0,"URL":"https:\/\/doi.org\/10.1055\/b-0034-81934","published":{"date-parts":[[2012]]}},{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:45:56Z","timestamp":1767134756725,"version":"build-2238731810"},"reference-count":95,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"DOI":"10.1002\/14651858.cd000208","type":"journal-article","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T22:14:00Z","timestamp":1069366440000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Miscellaneous treatments for neuroleptic-induced tardive dyskinesia"],"prefix":"10.1002","author":[{"given":"Karla","family":"Soares-Weiser","sequence":"first","affiliation":[{"name":"Enhance Reviews Ltd; Central Office, Cobweb Buildings The Lane, Lyford Wantage UK OX12 0EE"}]},{"given":"Claire B","family":"Irving","sequence":"additional","affiliation":[{"name":"The University of Nottingham; Cochrane Schizophrenia Group; Institute of Mental Health, Sir Colin Campbell Building University of Nottingham Innovation Park, Triumph Road Nottingham UK NG7 2TU"}]},{"given":"John","family":"Rathbone","sequence":"additional","affiliation":[{"name":"The University of Sheffield; HEDS, ScHARR; Regent Court 30 Regent Street Sheffield UK S1 4DA"}]}],"member":"311","published-online":{"date-parts":[[2003,4,22]]},"reference":[{"key":"10.1002\/14651858.CD000208-BIB0001|cit1","unstructured":"Elmsley R Oosthuizen PP Double-blind, randomized, parallel-group comparison of ethyl-eicosapentaenoic acid (ethyl-EP A) versus placebo as add-on medication in 84 patients with established tardive dyskinesia Stanley Foundation Research Programs 2002"},{"key":"10.1002\/14651858.CD000208-BIB0004|cit2","unstructured":"Emsley R A double-blind, randomised, parallel-group comparison of ethyl-eicosapentaenoic acid (ethyl-epa) versus placebo as add-on medication in patients with established tardive dyskinesia http:\/\/www.clinicaltrials.gov 2005"},{"key":"10.1002\/14651858.CD000208-BIB0005|cit3","unstructured":"Emsley R Ethyl eicosapentanoic acid for tardive dyskinesia Stanley Foundation Research Programs 2009"},{"issue":"1","key":"10.1002\/14651858.CD000208-BIB0002|cit4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.schres.2006.03.023","article-title":"The effects of eicosapentaenoic acid in tardive dyskinesia: a randomized, placebo-controlled trial","volume":"84","author":"Emsley","year":"2006","journal-title":"Schizophrenia Research"},{"issue":"3","key":"10.1002\/14651858.CD000208-BIB0003|cit5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.psychres.2007.06.029","article-title":"Safety of the omega-3 fatty acid, eicosapentaenoic acid (EPA) in psychiatric patients: results from a randomized, placebo-controlled trial","volume":"161","author":"Emsley","year":"2008","journal-title":"Psychiatry Research"},{"issue":"3","key":"10.1002\/14651858.CD000208-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0306-4530(85)90011-3","article-title":"Estrogen replacement and tardive dyskinesia","volume":"10","author":"Glazer","year":"1985","journal-title":"Psychoneuroendocrinology"},{"issue":"10","key":"10.1002\/14651858.CD000208-BIB0007|cit7","first-page":"2177","article-title":"Treatment of tardive dyskinesia with ceruletide: a double-blind placebo-controlled study","volume":"44","author":"Kojima","year":"1989","journal-title":"Saishin-Igaku"},{"issue":"2","key":"10.1002\/14651858.CD000208-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0165-1781(92)90127-O","article-title":"Treatment of tardive dyskinesia with ceruletide: a double-blind, placebo-controlled study","volume":"43","author":"Kojima","year":"1992","journal-title":"Psychiatry Research"},{"issue":"7","key":"10.1002\/14651858.CD000208-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.4088\/JCP.v68n0709","article-title":"Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover study","volume":"68","author":"Libov","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD000208-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1017\/S0033291700047498","article-title":"Failure of lithium treatment in established tardive dyskinesia","volume":"10","author":"Mackay","year":"1980","journal-title":"Psychological Medicine"},{"issue":"4","key":"10.1002\/14651858.CD000208-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0278-5846(88)90112-1","article-title":"The effect of ceruletide on tardive dyskinesia: a double-blind placebo-controlled study","volume":"12","author":"Matsunaga","year":"1988","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000208-BIB0013|cit12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0893-133X(96)00054-1","article-title":"Tardive dyskinesia exacerbated after ingestion of phenylalanine by schizophrenic patients","volume":"16","author":"Mosnik","year":"1997","journal-title":"Neuropsychopharmacology"},{"issue":"1, 2","key":"10.1002\/14651858.CD000208-BIB0012|cit13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0920-9964(95)95640-U","article-title":"Phenylalanine loading effects on tardive dyskinesia severity in schizophrenics","volume":"15","author":"Mosnik","year":"1995","journal-title":"Schizophrenia Research"},{"issue":"4","key":"10.1002\/14651858.CD000208-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000116678","article-title":"Low doses of insulin as a treatment of tardive dyskinesia: conjuncture or conjecture?","volume":"31","author":"Mouret","year":"1991","journal-title":"European Neurology"},{"issue":"7","key":"10.1002\/14651858.CD000208-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1176\/ajp.143.7.912","article-title":"Essential fatty acid supplementation in tardive dyskinesia","volume":"143","author":"Wolkin","year":"1986","journal-title":"American Journal of Psychiatry"},{"issue":"S1","key":"10.1002\/14651858.CD000208-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1365-2125.2000.00155.x","article-title":"The effects of ziprasidone on steady-state lithium levels and renal clearance of lithium","volume":"49","author":"Apseloff","year":"2000","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD000208-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF00427638","article-title":"Enkephalin, morphine, and naxoxone in tardive dyskinesia","volume":"69","author":"Bjorndal","year":"1980","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD000208-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00002826-198409000-00008","article-title":"Naloxone may be beneficial in the treatment of tardive dyskinesia","volume":"7","author":"Blum","year":"1984","journal-title":"Clinical Neuropharmacology"},{"issue":"4","key":"10.1002\/14651858.CD000208-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/BF00207250","article-title":"Naloxone in tardive dyskinesia","volume":"93","author":"Blum","year":"1987","journal-title":"Psychopharmacology Berlin"},{"issue":"2","key":"10.1002\/14651858.CD000208-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF00426727","article-title":"Tardive dyskinesia: a clinical test of the supersensitivity hypothesis","volume":"61","author":"Bowers","year":"1979","journal-title":"Psychopharmacology Berlin"},{"issue":"5","key":"10.1002\/14651858.CD000208-BIB0021|cit21","first-page":"281","article-title":"A controlled study on the treatment of tardive dyskinesia using 1-stepholidine","volume":"21","author":"Cai","year":"1988","journal-title":"Chinese Journal of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD000208-BIB0023|cit22","unstructured":"Casey DE Korsgaard S Gerlach J Des-tyr-gamma-endorphin in tardive dyskinesia Proceedings of the World Congress of Biological Psychiatry; 1981 June 28- July 3rd; Stockholm, Sweden 1981"},{"issue":"2","key":"10.1002\/14651858.CD000208-BIB0022|cit23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1001\/archpsyc.1981.01780270044005","article-title":"Effect of des-tyrosine-gamma -endorphin in tardive dyskinesia","volume":"38","author":"Casey","year":"1981","journal-title":"Archives of General Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD000208-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1176\/appi.ajp.159.9.1596","article-title":"Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia","volume":"159","author":"Emsley","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000208-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF01000185","article-title":"The effects of electromyographic feedback training on suppression of the oral-lingual movements associated with tardive dyskinesia","volume":"16","author":"Fudge","year":"1991","journal-title":"Biofeedback and Self Regulation"},{"issue":"2","key":"10.1002\/14651858.CD000208-BIB0026|cit26","first-page":"18","article-title":"Pilot study of cyproheptadine (Periactin) in tardive dyskinesia","volume":"14","author":"Gardos","year":"1978","journal-title":"Psychopharmacolgy Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD000208-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1055\/s-0028-1094443","article-title":"Effect of lithium on neuroleptic-induced tardive dyskinesia compared with placebo in a double-blind cross-over trial","volume":"8","author":"Gerlach","year":"1975","journal-title":"Pharmakopsychiatrie neuro-psychopharmakologie"},{"issue":"2","key":"10.1002\/14651858.CD000208-BIB0028|cit28","first-page":"138","article-title":"Studies on the action of certain pharmacological agents on tardive dykinesia and on the rabbit syndrome","volume":"9","author":"Jus","year":"1974","journal-title":"International Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD000208-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000117629","article-title":"Deanol, lithium and placebo in the treatment of tardive dyskinesia: A double-blind crossover study","volume":"4","author":"Jus","year":"1978","journal-title":"Neuropsychobiology"},{"key":"10.1002\/14651858.CD000208-BIB0030|cit30","unstructured":"Kabes J Sikora J Pisvejc J Skoudia V Piracetam action in neuroleptic induced extrapyramidal side-effects Proceedings of the 12th CINP congress; Supplement to Progress in Neuropsychopharmacology Pergamon Press 1980"},{"issue":"3","key":"10.1002\/14651858.CD000208-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000468574","article-title":"Effect of piracetam on extrapyramidal side effects induced by neuroleptic drugs","volume":"17","author":"Kabes","year":"1982","journal-title":"International Pharmacopsychiatry"},{"issue":"5","key":"10.1002\/14651858.CD000208-BIB0032|cit32","first-page":"339","article-title":"Piracetam effectivity in tardive dyskinesia. A double-blind placebo-controlled cross-over trial","volume":"79","author":"Kabes","year":"1983","journal-title":"Ceskoslovenska Psychiatrie"},{"issue":"2","key":"10.1002\/14651858.CD000208-BIB0033|cit33","first-page":"137","article-title":"Management of neuroleptic side-effects with piracetam","volume":"77","author":"Sikora","year":"1981","journal-title":"Ceskoslovenska Psychiatrie"},{"issue":"4","key":"10.1002\/14651858.CD000208-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF00432752","article-title":"Vasopressin in anergic schizophrenia: a cross-over study with lysine-8-vasopressin and placebo","volume":"74","author":"Korsgaard","year":"1981","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD000208-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0165-1781(88)90083-2","article-title":"High-dose naloxone in tardive dyskinesia","volume":"26","author":"Lindenmayer","year":"1988","journal-title":"Psychiatry Research"},{"issue":"3","key":"10.1002\/14651858.CD000208-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/BF00464572","article-title":"Serotonin precursor effects in tardive dyskinesia","volume":"77","author":"Nasrallah","year":"1982","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD000208-BIB0037|cit37","first-page":"277","article-title":"GM1 ganglioside as a potential treatment in tardive dyskinesia","volume":"25","author":"Peselow","year":"1989","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000208-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/089198879400700408","article-title":"Changes in tardive dyskinesia symptoms in elderly patients with ganglioside GM1 or placebo","volume":"7","author":"Sommer","year":"1994","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"key":"10.1002\/14651858.CD000208-BIB0039|cit39","first-page":"36","article-title":"Preliminary experience with tryptophan and lithium in the treatment of tardive dyskinesia","volume":"9","author":"Prange","year":"1973","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000208-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1176\/ajp.132.5.560","article-title":"Lithium carbonate in the treatment of tardive dyskinesia","volume":"132","author":"Reda","year":"1975","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000208-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1056\/NEJM197410172911617","article-title":"Treatment of tardive dyskinesia with lithium carbonate","volume":"291","author":"Reda","year":"1974","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD000208-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0165-1781(82)90068-3","article-title":"Naloxone, tardive dyskinesia, and endogenous beta-endorphin","volume":"7","author":"Reker","year":"1982","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD000208-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1749-6632.1982.tb39480.x","article-title":"Naloxone and naltrexone in mental illness and tardive dyskinesia","volume":"398","author":"Volavka","year":"1982","journal-title":"Annals of New York Academy of Sciences"},{"issue":"2","key":"10.1002\/14651858.CD000208-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1055\/s-0028-1094481","article-title":"Lithium in tardive dyskinesia","volume":"9","author":"Simpson","year":"1976","journal-title":"Pharmakopsychiatrie neuro-psychopharmakologie"},{"issue":"1","key":"10.1002\/14651858.CD000208-BIB0045|cit45","first-page":"87","article-title":"An early clinical and toxicity trial of EX 11-582A in chronic schizophrenia","volume":"19","author":"Simpson","year":"1976","journal-title":"Current Therapeutic Research"},{"issue":"3","key":"10.1002\/14651858.CD000208-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0165-1781(89)90146-7","article-title":"A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia","volume":"27","author":"Vaddadi","year":"1989","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD000208-BIB0047|cit47","doi-asserted-by":"crossref","unstructured":"Villeneuve A Boszormenyi Z Treatment of drug-induced dyskinesias Lancet 1970","DOI":"10.1016\/S0140-6736(70)90724-5"},{"issue":"3","key":"10.1002\/14651858.CD000208-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000117746","article-title":"Estrogens in tardive dyskinesia in male psychiatric patients","volume":"6","author":"Villeneuve","year":"1980","journal-title":"Neuropsychobiology"},{"issue":"2","key":"10.1002\/14651858.CD000208-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0165-1781(86)90002-8","article-title":"Lithium and lecithin in tardive dyskinesia: an update","volume":"19","author":"Volavka","year":"1986","journal-title":"Psychiatry Research"},{"issue":"4","key":"10.1002\/14651858.CD000208-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/01.jcp.0000132440.27854.44","article-title":"Naltrexone treatment of tardive dyskinesia in patients with schizophrenia","volume":"24","author":"Wonodi","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"11","key":"10.1002\/14651858.CD000208-BIB0051|cit51","first-page":"3","article-title":"Piracetam reduces TD symptomstardive dyskinesia","volume":"18","author":"Anon","year":"2007","journal-title":"Brown University Psychopharmacology Update"},{"issue":"1","key":"10.1002\/14651858.CD000208-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00369796","article-title":"Deanol in tardive dyskinesia: a double-blind study","volume":"222","author":"Bockenheimer","year":"1976","journal-title":"Archiv F\u00fcr Psychiatrie Und Nervenkrankheiten"},{"key":"10.1002\/14651858.CD000208-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1212\/WNL.32.5.547","article-title":"Estrogen treatment of dyskinetic disorders","volume":"32","author":"Koller","year":"1982","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000208-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000208-BIB0055|cit55","article-title":"Tardive dyskinesia: a task force report of the American Psychiatric Association","volume-title":"American Psychiatric Association","author":"American Psychiatric Association","year":"1992"},{"key":"10.1002\/14651858.CD000208-BIB0056|cit56","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-079035-7.50021-X","article-title":"The side-effects of antipsychotic drugs. I. CNS and neuromuscular effects","volume-title":"Antipsychotic drugs and their side-effects","author":"Barnes","year":"1993"},{"issue":"1","key":"10.1002\/14651858.CD000208-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000205.pub2","article-title":"Benzodiazapines for neuroleptic-induced tardive dyskinesia","author":"Bhoopathi","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000208-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD000208-BIB0059|cit59","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD000208-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM199403103301006","article-title":"Schizophrenia","volume":"330","author":"Carpenter","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000208-BIB0061|cit61","first-page":"233","article-title":"Extrapyramidal symptom rating scale","volume":"7","author":"Chouinard","year":"1980","journal-title":"Canadian Journal of Neurological Science"},{"key":"10.1002\/14651858.CD000208-BIB0062|cit62","unstructured":"Clarke M Oxman AD Cochrane Collaboration Handbook The Cochrane Library [database on disk and CDROM]. The Cochrane Collaboration 2000"},{"key":"10.1002\/14651858.CD000208-BIB0063|cit63","unstructured":"Deeks J Issues in the selection for meta-analyses of binary data Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28th; Cape Town, South Africa 2000"},{"key":"10.1002\/14651858.CD000208-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD000208-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"7109","key":"10.1002\/14651858.CD000208-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"British Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD000208-BIB0067|cit67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000458.pub2","article-title":"Non-neuroleptic catecholaminergic drugs for neuroleptic-induced tardive dyskinesia","author":"El-Sayeh","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000208-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD000208-BIB0069|cit69","first-page":"281","article-title":"Tardive dyskinesia and diabetes mellitus","volume":"28","author":"Ganzini","year":"1992","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000208-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD000208-BIB0071|cit71","first-page":"534","article-title":"ECDEU","volume-title":"Assessment Manual for Psychopharmacology, Revised","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD000208-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000208-BIB0073|cit73","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"key":"10.1002\/14651858.CD000208-BIB0074|cit74","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009] The Cochrane Collaboration, 2009 www.cochrane-handbook.org 2009","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD000208-BIB0075|cit75","volume-title":"Positive and negative syndrome scale (PANSS) manual","author":"Kay","year":"1986"},{"key":"10.1002\/14651858.CD000208-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of Brief Psychiatric Rating Scale Scores","volume":"187","author":"Leucht","year":"2005","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000208-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD000208-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"issue":"9263","key":"10.1002\/14651858.CD000208-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials","volume":"357","author":"Moher","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000208-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"issue":"4","key":"10.1002\/14651858.CD000208-BIB0081|cit81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000203.pub2","article-title":"Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia","author":"Rathbone","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000208-BIB0082|cit82","volume-title":"L'examen clinique en psychologie","author":"Rey","year":"1964"},{"key":"10.1002\/14651858.CD000208-BIB0083|cit83","volume-title":"Modern Psychometrics","author":"Rust","year":"1989"},{"key":"10.1002\/14651858.CD000208-BIB0084|cit84","first-page":"431","article-title":"Clinical research for the treatment of schizophrenia","volume":"29","author":"Schooler","year":"1993","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000208-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00496058","article-title":"A rating scale for tardive dyskinesia","volume":"64","author":"Simpson","year":"1979","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD000208-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000209","article-title":"Vitamin E for neuroleptic-induced tardive dyskinesia","author":"Soares","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD000208-BIB0087|cit87","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000204","article-title":"Anticholinergic medication for neuroleptic-induced tardive dyskinesia","author":"Soares","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD000208-BIB0088|cit88","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000206.pub2","article-title":"Calcium channel blockers for neuroleptic-induced tardive dyskinesia","author":"Soares-Weiser","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD000208-BIB0089|cit89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000459.pub2","article-title":"Neuroleptic reduction and\/or cessation and neuroleptics as specific treatments for tardive dyskinesia","author":"Soares-Weiser","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD000208-BIB0090|cit90","article-title":"Cholinergic medication for neuroleptic induced-tardive dyskinesia","author":"Tammenmaa","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD000208-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organistation-based intervention in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD000208-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1176\/ajp.150.6.966","article-title":"Diabetes and development of tardive dyskinesia","volume":"150","author":"Woerner","year":"1993","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000208-BIB0093|cit93","unstructured":"Xia J Adams CE Bhagat N Bhagat V Bhoopathi P El-Sayeh H Pinfold V Takriti Y The Leeds Outcomes Stakeholders Survey (LOSS) Study Proceddings of the15th Cochrane Colloquium; 2007 Oct 23-27; Sao Paulo 2007"},{"issue":"2","key":"10.1002\/14651858.CD000208-BIB0094|cit94","article-title":"Miscellaneous treatments for tardive dyskinesia","author":"McGrath","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD000208-BIB0095|cit95","article-title":"Miscellaneous treatments for neuroleptic-induced tardive dyskinesia","author":"Soares-Weiser","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd000208.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T00:00:00Z","timestamp":1521417600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD000208\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T16:55:24Z","timestamp":1628528124000},"score":18.254717,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD000208"}},"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[]}],"issued":{"date-parts":[[2003,4,22]]},"references-count":95,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000208","ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"published":{"date-parts":[[2003,4,22]]}},{"indexed":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T17:07:50Z","timestamp":1714756070307},"reference-count":10,"publisher":"Elsevier","isbn-type":[{"value":"9780080292007","type":"print"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[1987]]},"DOI":"10.1016\/b978-0-08-029200-7.50025-4","type":"book-chapter","created":{"date-parts":[[2013,11,18]],"date-time":"2013-11-18T14:27:12Z","timestamp":1384784832000},"page":"553-581","source":"Crossref","is-referenced-by-count":0,"title":["Miscellaneous Hydrocarbon Systems"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/B978-0-08-029200-7.50025-4_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1021\/je00023a018","volume":"26","author":"Li","year":"1981","journal-title":"J. Chem. Eng. Data"},{"key":"10.1016\/B978-0-08-029200-7.50025-4_bib2","unstructured":"Koonce, K. T. Ph.D. thesis, Rice University, Houston, 1963."},{"key":"10.1016\/B978-0-08-029200-7.50025-4_bib3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/aic.690230410","volume":"23","author":"Simnick","year":"1977","journal-title":"Am. Inst. Chem. Eng. J."},{"key":"10.1016\/B978-0-08-029200-7.50025-4_bib4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/aic.690230410","volume":"23","author":"Simnick","year":"1977","journal-title":"Am. Inst. Chem. Eng. J."},{"key":"10.1016\/B978-0-08-029200-7.50025-4_bib5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1021\/ja01269a023","volume":"60","author":"Brunaur","year":"1938","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/B978-0-08-029200-7.50025-4_bib6","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/cjce.5450580506","volume":"58","author":"Vorndran","year":"1980","journal-title":"Can. J. Chem. Eng."},{"key":"10.1016\/B978-0-08-029200-7.50025-4_bib7","first-page":"95","volume":"21","author":"Mehrotra","year":"1982","journal-title":"JCPT, J. Can. Pet. Technol."},{"key":"10.1016\/B978-0-08-029200-7.50025-4_bib8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/aic.690230410","volume":"23","author":"Simnick","year":"1877","journal-title":"A. I. Ch. E. J."},{"key":"10.1016\/B978-0-08-029200-7.50025-4_bib9","unstructured":"Srinivasan, R. Ph. D. Thesis, Department Gas Engineering, IIT, Chicago, IL 1981."},{"key":"10.1016\/B978-0-08-029200-7.50025-4_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/zaac.19221240109","volume":"124","author":"Fischer","year":"1922","journal-title":"Z. Anorg. Chem."}],"container-title":["Methane"],"language":"en","deposited":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T06:11:43Z","timestamp":1564726303000},"score":18.130135,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780080292007500254"}},"issued":{"date-parts":[[1987]]},"ISBN":["9780080292007"],"references-count":10,"URL":"https:\/\/doi.org\/10.1016\/b978-0-08-029200-7.50025-4","published":{"date-parts":[[1987]]}},{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T20:29:09Z","timestamp":1762288149445,"version":"build-2065373602"},"reference-count":0,"publisher":"BMJ Publishing Group Ltd","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1136\/ijgc-2021-esgo.250","type":"proceedings-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T11:40:54Z","timestamp":1634125254000},"page":"A151.2-A152","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["69\u2005Surgical and medical treatments for uterine PEComas"],"prefix":"10.1016","author":[{"given":"G","family":"Bogani","sequence":"first","affiliation":[{"name":"Fondazione IRCCS Istituto Nazionale dei Tumori , Milano, Italy"}]},{"given":"A","family":"Gronchi","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Istituto Nazionale dei Tumori , Milano, Italy"}]},{"given":"A","family":"Ditto","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Istituto Nazionale dei Tumori , Milano, Italy"}]},{"given":"F","family":"Raspagliesi","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Istituto Nazionale dei Tumori , Milano, Italy"}]}],"member":"78","published-online":{"date-parts":[[2021,10,12]]},"event":{"name":"ESGO 2021 Congress"},"container-title":["Miscellaneous"],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2021-ESGO.250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T20:20:40Z","timestamp":1762287640000},"score":18.103577,"resource":{"primary":{"URL":"https:\/\/ijgc.bmj.com\/lookup\/doi\/10.1136\/ijgc-2021-ESGO.250"}},"issued":{"date-parts":[[2021,10]]},"references-count":0,"alternative-id":["10.1136\/ijgc-2021-ESGO.250"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2021-esgo.250","published":{"date-parts":[[2021,10]]}},{"indexed":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T20:33:00Z","timestamp":1714768380439},"reference-count":35,"publisher":"Elsevier","isbn-type":[{"value":"9780080347103","type":"print"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[1989]]},"DOI":"10.1016\/b978-0-08-034710-3.50014-3","type":"book-chapter","created":{"date-parts":[[2013,11,20]],"date-time":"2013-11-20T09:00:21Z","timestamp":1384938021000},"page":"426-485","source":"Crossref","is-referenced-by-count":0,"title":["miscellaneous systems"],"prefix":"10.1016","member":"78","reference":[{"issue":"3","key":"10.1016\/B978-0-08-034710-3.50014-3_bib1","first-page":"589","volume":"89","author":"Tskitishvili","year":"1978","journal-title":"Soobshch. Akad. Nauk Gruz. SSR"},{"issue":"3","key":"10.1016\/B978-0-08-034710-3.50014-3_bib2","first-page":"589","volume":"89","author":"Tskitishvili","year":"1978","journal-title":"Soobshch. Akad. Nauk Gruz. SSR"},{"issue":"3","key":"10.1016\/B978-0-08-034710-3.50014-3_bib3","first-page":"589","volume":"89","author":"Tskitishvili","year":"1978","journal-title":"Soobshch. Akad. Nauk Gruz. SSR"},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/jac\/8.2.133","volume":"8","author":"Hekster","year":"1981","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/jac\/8.2.133","volume":"8","author":"Hekster","year":"1981","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib6","first-page":"4","volume":"66","author":"Bratton","year":"1939","journal-title":"J. Pharmacol."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib7","first-page":"4","volume":"66","author":"Bratton","year":"1939","journal-title":"J. Pharmacol."},{"issue":"1","key":"10.1016\/B978-0-08-034710-3.50014-3_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jps.3030360105","volume":"36","author":"Burlage","year":"1947","journal-title":"J. Am. Pharm. Assoc., Sci. Ed."},{"issue":"1","key":"10.1016\/B978-0-08-034710-3.50014-3_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jps.3030360105","volume":"36","author":"Burlage","year":"1947","journal-title":"J. Am. Pharm. Assoc., Sci. Ed."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib10","first-page":"4","volume":"66","author":"Bratton","year":"1939","journal-title":"J. Pharmacol."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0021-9258(18)73708-3","volume":"128","author":"Bratton","year":"1939","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF01782957","author":"Havemann","year":"1940","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0021-9258(18)73708-3","volume":"128","author":"Bratton","year":"1939","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF01782957","author":"Havemann","year":"1940","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0021-9258(18)73708-3","volume":"128","author":"Bratton","year":"1939","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF01782957","author":"Havemann","year":"1940","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0021-9258(18)73708-3","volume":"128","author":"Bratton","year":"1939","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib18","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0021-9258(18)73708-3","volume":"128","author":"Bratton","year":"1939","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib19","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0021-9258(18)73708-3","volume":"128","author":"Bratton","year":"1939","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0021-9258(18)73708-3","volume":"128","author":"Bratton","year":"1939","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF01782957","author":"Havemann","year":"1940","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0021-9258(18)73708-3","volume":"128","author":"Bratton","year":"1939","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib23","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0021-9258(18)73708-3","volume":"128","author":"Bratton","year":"1939","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib24","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0021-9258(18)73708-3","volume":"128","author":"Bratton","year":"1939","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0021-9258(18)73708-3","volume":"128","author":"Bratton","year":"1939","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0021-9258(18)73708-3","volume":"128","author":"Bratton","year":"1939","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib27","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jps.3030410702","volume":"41","author":"Biamonte","year":"1952","journal-title":"J. Am. Pharm. Assoc., Sci. Ed."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib28","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0021-9258(18)73708-3","volume":"128","author":"Bratton","year":"1939","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib29","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF01782957","author":"Havemann","year":"1940","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib30","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0021-9258(18)73708-3","volume":"128","author":"Bratton","year":"1939","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jps.3030410702","volume":"41","author":"Biamonte","year":"1952","journal-title":"J. Am. Pharm. Assoc., Sci. Ed."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jps.3030410702","volume":"41","author":"Biamonte","year":"1952","journal-title":"J. Am. Pharm. Assoc., Sci. Ed."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib33","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0021-9258(18)73708-3","volume":"128","author":"Bratton","year":"1939","journal-title":"J. Biol. Chem."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib34","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jps.3030410702","volume":"41","author":"Biamonte","year":"1952","journal-title":"J, Am. Pharm. Assoc., Sci. Ed."},{"key":"10.1016\/B978-0-08-034710-3.50014-3_bib35","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0021-9258(18)73708-3","volume":"128","author":"Bratton","year":"1939","journal-title":"J. Biol. Chem."}],"container-title":["4\u2013Aminobenzenesulfonamides"],"language":"en","deposited":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T06:01:10Z","timestamp":1647410470000},"score":18.075333,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780080347103500143"}},"issued":{"date-parts":[[1989]]},"ISBN":["9780080347103"],"references-count":35,"URL":"https:\/\/doi.org\/10.1016\/b978-0-08-034710-3.50014-3","published":{"date-parts":[[1989]]}},{"institution":[{"name":"Pacific Northwest National Laboratory (PNNL)","acronym":["PNNL"],"place":["Richland, WA (United States)"]},{"name":"Not Available"}],"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T22:34:16Z","timestamp":1648679656720},"reference-count":0,"publisher":"Office of Scientific and Technical Information (OSTI)","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.2172\/5512909","type":"report","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T02:16:40Z","timestamp":1339467400000},"approved":{"date-parts":[[2012,6,11]]},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of alternative treatments for spent fuel rod consolidation wastes and other miscellaneous commercial transuranic wastes"],"prefix":"10.2172","author":[{"given":"W.A.","family":"Ross","sequence":"first","affiliation":[]},{"given":"K.J.","family":"Schneider","sequence":"additional","affiliation":[]},{"given":"K.H.","family":"Oma","sequence":"additional","affiliation":[]},{"given":"R.I.","family":"Smith","sequence":"additional","affiliation":[]},{"given":"L.R.","family":"Bunnell","sequence":"additional","affiliation":[]}],"member":"960","published-online":{"date-parts":[[1986,5,1]]},"deposited":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T02:16:40Z","timestamp":1339467400000},"score":18.038326,"resource":{"primary":{"URL":"http:\/\/www.osti.gov\/servlets\/purl\/5512909\/"}},"issued":{"date-parts":[[1986,5,1]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2172\/5512909","published":{"date-parts":[[1986,5,1]]}},{"indexed":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T04:32:37Z","timestamp":1727238757510},"publisher-location":"Boca Raton","edition-number":"1","reference-count":0,"publisher":"CRC Press","isbn-type":[{"value":"9781003573906","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2024,9,24]]},"DOI":"10.1201\/9781003573906-7","type":"book-chapter","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T17:17:34Z","timestamp":1727198254000},"page":"395-408","source":"Crossref","is-referenced-by-count":0,"title":["Miscellaneous Piping Systems"],"prefix":"10.1201","author":[{"given":"Philip A.","family":"Schweitzer","sequence":"first","affiliation":[]}],"member":"301","container-title":["Corrosion-Resistant Piping Systems"],"language":"en","deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T17:17:42Z","timestamp":1727198262000},"score":17.964775,"resource":{"primary":{"URL":"https:\/\/www.taylorfrancis.com\/books\/9781003573906\/chapters\/10.1201\/9781003573906-7"}},"issued":{"date-parts":[[2024,9,24]]},"ISBN":["9781003573906"],"references-count":0,"URL":"https:\/\/doi.org\/10.1201\/9781003573906-7","published":{"date-parts":[[2024,9,24]]}},{"indexed":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T01:57:04Z","timestamp":1714183024701},"publisher-location":"Oxford","reference-count":0,"publisher":"Logos","content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[1958]]},"DOI":"10.1037\/10604-011","type":"book-chapter","created":{"date-parts":[[2004,12,14]],"date-time":"2004-12-14T20:59:05Z","timestamp":1103057945000},"page":"456-472","source":"Crossref","is-referenced-by-count":0,"title":["Miscellaneous somatic treatments: The relationship of somatic therapy to psychotherapy."],"prefix":"10.1037","author":[{"given":"Paul H.","family":"Hoch","sequence":"first","affiliation":[]},{"given":"Harry H.","family":"Pennes","sequence":"additional","affiliation":[]}],"member":"15","container-title":["Schizophrenia: A review of the syndrome."],"language":"en","link":[{"URL":"http:\/\/psycnet.apa.org\/books\/10604\/011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T18:36:32Z","timestamp":1708713392000},"score":17.878944,"resource":{"primary":{"URL":"https:\/\/content.apa.org\/books\/10604-011"}},"issued":{"date-parts":[[1958]]},"references-count":0,"alternative-id":["1959-06638-011","1959-06638-000"],"URL":"https:\/\/doi.org\/10.1037\/10604-011","published":{"date-parts":[[1958]]}},{"indexed":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:12:19Z","timestamp":1654906339527},"edition-number":"1","reference-count":0,"publisher":"Cambridge University Press","license":[{"start":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T00:00:00Z","timestamp":1450396800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2016,1,7]]},"DOI":"10.1017\/cbo9781316562857.002","type":"book-chapter","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T10:46:24Z","timestamp":1450435584000},"page":"xiii-xiii","source":"Crossref","is-referenced-by-count":0,"title":["Miscellaneous Frontmatter"],"prefix":"10.1017","member":"56","container-title":["Noncommutative Mathematics for Quantum Systems"],"link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/D8AEB70B574123D663583853EAAD2480","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T23:38:10Z","timestamp":1654904290000},"score":17.857878,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/CBO9781316562857A008\/type\/book_part"}},"issued":{"date-parts":[[2016,1,7]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1017\/cbo9781316562857.002","published":{"date-parts":[[2016,1,7]]}},{"indexed":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T04:33:21Z","timestamp":1727238801456},"publisher-location":"Boca Raton","edition-number":"1","reference-count":0,"publisher":"CRC Press","isbn-type":[{"value":"9781003573906","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2024,9,24]]},"DOI":"10.1201\/9781003573906-5","type":"book-chapter","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T17:17:34Z","timestamp":1727198254000},"page":"191-223","source":"Crossref","is-referenced-by-count":0,"title":["Miscellaneous Lined Piping Systems"],"prefix":"10.1201","author":[{"given":"Philip A.","family":"Schweitzer","sequence":"first","affiliation":[]}],"member":"301","container-title":["Corrosion-Resistant Piping Systems"],"language":"en","deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T17:17:41Z","timestamp":1727198261000},"score":17.668505,"resource":{"primary":{"URL":"https:\/\/www.taylorfrancis.com\/books\/9781003573906\/chapters\/10.1201\/9781003573906-5"}},"issued":{"date-parts":[[2024,9,24]]},"ISBN":["9781003573906"],"references-count":0,"URL":"https:\/\/doi.org\/10.1201\/9781003573906-5","published":{"date-parts":[[2024,9,24]]}},{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T12:35:25Z","timestamp":1725453325959},"publisher-location":"New York City","reference-count":0,"publisher":"Grune & Stratton","content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[1948]]},"DOI":"10.1037\/10777-011","type":"book-chapter","created":{"date-parts":[[2005,7,12]],"date-time":"2005-07-12T18:55:32Z","timestamp":1121194532000},"page":"309-331","source":"Crossref","is-referenced-by-count":0,"title":["Miscellaneous Studies on Various and Combined Shock Treatments."],"prefix":"10.1037","author":[{"given":"Leopold","family":"Bellak","sequence":"first","affiliation":[]}],"member":"15","container-title":["Dementia praecox: The past decade's work and present status: A review and evaluation."],"language":"en","link":[{"URL":"http:\/\/psycnet.apa.org\/books\/10777\/011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T18:33:34Z","timestamp":1708713214000},"score":17.587273,"resource":{"primary":{"URL":"https:\/\/content.apa.org\/books\/10777-011"}},"issued":{"date-parts":[[1948]]},"references-count":0,"alternative-id":["2005-06588-011","2005-06588-000"],"URL":"https:\/\/doi.org\/10.1037\/10777-011","published":{"date-parts":[[1948]]}},{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:28:56Z","timestamp":1760016536414},"reference-count":225,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.1016\/s0738-081x(99)00103-0","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T12:06:19Z","timestamp":1027598779000},"page":"131-145","source":"Crossref","is-referenced-by-count":21,"title":["Miscellaneous treatments: thalidomide, potassium iodide, levamisole, clofazimine, colchicine, and d-Penicillamine"],"prefix":"10.1016","volume":"18","author":[{"given":"Miguel R","family":"Sanchez","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0738-081X(99)00103-0_BIB1","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-4362.1980.tb00342.x","article-title":"The treatment of lepra reaction in lepromatous leprosy. Fifteen years\u2019 experience with thalidomide","volume":"19","author":"Sheskin","year":"1980","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB2","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0190-9622(96)90122-X","article-title":"Rediscovering thalidomide","volume":"35","author":"Tseng","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB3","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/infdis\/168.2.408","article-title":"The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum","volume":"168","author":"Sampaio","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB4","first-page":"1480","article-title":"Jekyll and Hyde","volume":"89","author":"Saphir","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB5","unstructured":"Haslett PA. Anticytokine approaches to the treatment of anorexia and cachexia. Semin Oncol 1998;25(2 Suppl 6):53\u20137."},{"key":"10.1016\/S0738-081X(99)00103-0_BIB6","first-page":"201","article-title":"Thalidomide\u2014effect on T-cell subsets as a possible mechanism of action","volume":"53","author":"Moncada","year":"1985","journal-title":"Int J Leprother Mycobac Dis"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB7","first-page":"1487","article-title":"Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection","volume":"336","author":"Jacobson","year":"1997","journal-title":"National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/clinids\/23.3.501","article-title":"Regression of AIDS-related Kaposi\u2019s sarcoma during therapy with thalidomide","volume":"23","author":"Soler","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00001813-199605000-00015","article-title":"The effect of thalidomide on experimental tumors and metastases","volume":"7","author":"Minchinton","year":"1996","journal-title":"Anticancer Drugs"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB10","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1056\/NEJM199204163261604","article-title":"Thalidomide for the treatment of chronic graft-versus-host disease","volume":"326","author":"Vogelsand","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-4362.1985.tb05400.x","article-title":"Thalidomide therapy. An open trial","volume":"24","author":"Naafs","year":"1985","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB12","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1001\/archderm.129.12.1548","article-title":"Chronic cutaneous lupus erythematosus treated with thalidomide","volume":"129","author":"Holm","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2165\/00002018-199512060-00002","article-title":"Thalidomide","volume":"12","author":"Schuler","year":"1995","journal-title":"Drug Safety"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2340\/0001555564412417","article-title":"Thalidomie treatment of prurigo nodularis","volume":"64","author":"Winkelmann","year":"1984","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB15","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-4362.1992.tb02732.x","article-title":"Cellular immune effects of thalidomide in actinic prurigo (letter)","volume":"31","author":"Bernal","year":"1992","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB16","first-page":"74","article-title":"Managing PLE and actinic prurigo","volume":"241","author":"Grabczyska","year":"1997","journal-title":"Practitioner"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000187978","article-title":"Thalidomide for the treatment of uremic pruritus","volume":"67","author":"Silva","year":"1994","journal-title":"Nephron"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB18","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0190-9622(98)70513-4","article-title":"Recalcitrant pyoderma gangrenosum","volume":"38","author":"Hecker","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB19","first-page":"375","article-title":"Treatment of thalidomide of chronic multiforme erythema","volume":"23","author":"Cherouati","year":"1996","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB20","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/0190-9622(95)91549-4","article-title":"Treatment of cutaneous and pulmonary sarcoidosis with thalidomide","volume":"32","author":"Carlesimo","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-4362.1985.tb05400.x","article-title":"Thalidomide therapy. An open trial","volume":"24","author":"Naafs","year":"1985","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB22","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archinte.146.5.878","article-title":"Thalidomide effects in Behcet\u2019s syndrome and pustular vasculitis","volume":"146","author":"Jorizzo","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB23","doi-asserted-by":"crossref","first-page":"494","DOI":"10.7326\/0003-4819-128-6-199803150-00011","article-title":"Behcet\u2019s disease and the emergence of thalidomide","volume":"128","author":"Ehrlich","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF02054255","article-title":"Treatment of Behcet\u2019s disease with thalidomide","volume":"5","author":"Hamza","year":"1986","journal-title":"Clin Rheumatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(77)91039-X","article-title":"Thalidomide in Weber-Christian disease (letter)","volume":"1","author":"Eravelly","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB26","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/archderm.132.11.1392","article-title":"Erosive lichen planus","volume":"132","author":"Dereure","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB27","first-page":"104","article-title":"Thalidomide and ulcerative colitis in Behcet\u2019s disease (letter)","volume":"13","author":"Patey","year":"1989","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB28","first-page":"250","article-title":"Thalidomide in oral Crohn\u2019s disease refractory to conventional medical treatment (letter)","volume":"35","author":"Odeka","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB29","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1089\/aid.1997.13.1047","article-title":"The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with the human immunodeficiency virus","volume":"13","author":"Haslett","year":"1997","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB30","first-page":"487","article-title":"Treatment of the cutaneous lesions of systemic lupus erythematosus with thalidomide","volume":"11","author":"Atra","year":"1993","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0190-9622(98)70096-9","article-title":"Thalidomide for recalcitrant discoid lesions in a patient with systemic lupus erythematosus","volume":"39","author":"Warren","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/rheumatology\/36.3.353","article-title":"Thalidomide in the treatment of the cutaneous manifestations of lupus erythematosus","volume":"36","author":"Stevens","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB33","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-4362.1984.tb05696.x","article-title":"Thalidomide therapy for inflammatory dermatoses","volume":"23","author":"Grosshaus","year":"1984","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB34","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-4362.1989.tb04599.x","article-title":"Treatment of discoid lupus erythematosus","volume":"28","author":"Lo","year":"1989","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB35","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2133.1983.tb04600.x","article-title":"Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus","volume":"108","author":"Knop","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB36","first-page":"158","article-title":"Treatment of refractory rheumatoid arthritis\u2014the thalidomide experience","volume":"16","author":"Gutierrez-Rodriguez","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB37","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0140-6736(05)79252-7","article-title":"TNF-alpha and response of treatment resistant adult-onset Still\u2019s disease to thalidomide (letter)","volume":"52","author":"Stambe","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB38","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archderm.126.7.923","article-title":"Crossover study of thalidomide vs. placebo in severe recurrent aphthous stomatitis","volume":"126","author":"Revuz","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB39","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/clinids\/20.2.250","article-title":"Thalidomide as treatment of refractory aphthous ulceration related to human immunodeficiency virus infection","volume":"20","author":"Paterson","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB40","first-page":"103","article-title":"Thalidomide","volume":"40","author":"Anonymous","year":"1998","journal-title":"Med Lett Drugs Ther"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB41","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1089\/aid.1997.13.301","article-title":"A prospective trial of thalidomide for the treatment of HIV-associated idiopathic esophageal ulcers","volume":"13","author":"Alexander","year":"1997","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB42","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/archderm.131.9.1032","article-title":"Crossover study of thalidomine vs. placebo in Jessner\u2019s lymphocytic infiltration of the skin","volume":"131","author":"Guillaume","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB43","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1182\/blood.V86.9.3604.bloodjournal8693604","article-title":"Thalidomide as salvage therapy for chronic graft-versus-host disease","volume":"86","author":"Parker","year":"1995","journal-title":"Blood"},{"issue":"Suppl 3","key":"10.1016\/S0738-081X(99)00103-0_BIB44","first-page":"S26","article-title":"Thalidomide\u2014the need for a new clinical evaluation of an old drug","volume":"12","author":"Ehninger","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB45","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/sj.bmt.1701138","article-title":"The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children","volume":"21","author":"Rovelli","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB46","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000245988","article-title":"Sequential combined therapy with thalidomide and narrow-band (TL01) UVB in the treatment of prurigo nodularis","volume":"195","author":"Ferrandiz","year":"1997","journal-title":"Dermatology"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB47","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2133.1983.tb04601.x","article-title":"Thalidomide in actinic prurigo","volume":"108","author":"Lovell","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1440-0960.1976.tb00577.x","article-title":"Polymorphous light eruption","volume":"17","author":"Saul","year":"1976","journal-title":"Australas J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB49","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2230.1977.tb01577.x","article-title":"Actinic prurigo (Hutchinson\u2019s summer prurigo)","volume":"32","author":"Calnan","year":"1977","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB50","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-4362.1973.tb00066.x","article-title":"Thalidomide in the treatment of actinic prurigo","volume":"12","author":"Londano","year":"1973","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB51","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0190-9622(98)70360-3","article-title":"Disfiguring cutaneous manifestation of sarcoidosis treated with thalidomide","volume":"39","author":"Lee","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB52","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0190-9622(08)80705-0","article-title":"Pyoderma ganrenosum associated with Behcet\u2019s disease","volume":"23","author":"Rustin","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB53","first-page":"408","article-title":"Pyoderma ganrenosum associated with Behcet\u2019s syndrome","volume":"13","author":"Munro","year":"1998","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB54","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0248-8663(97)80720-5","article-title":"Langerhans histiocytosis in adults","volume":"19","author":"Lair","year":"1998","journal-title":"Rev Med Interne"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB55","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/archderm.129.10.1261","article-title":"Successful treatment of adult\u2019s Langerhans cell histiocytosis with thalidomide. Report of two cases and literature review","volume":"129","author":"Thomas","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB56","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/026921639801200312","article-title":"Thalidomide for distressing night sweats in advanced malignant disease (letter)","volume":"12","author":"Deaner","year":"1998","journal-title":"Palliative Med"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB57","first-page":"116","volume":"7","author":"Gunzler","year":"1992","journal-title":"Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations. Drug Safety"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB58","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2133.1985.tb02323.x","article-title":"Development of polyneuropathy during thalidomide therapy","volume":"112","author":"Wulff","year":"1985","journal-title":"Br J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB59","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000246827","article-title":"Erythroderma due to thalidomide","volume":"189","author":"Bielsa","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB60","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1097\/00002030-199611000-00007","article-title":"Effects of thalidomide on HIV-associated wasting syndrome","volume":"10","author":"Reyes-Teran","year":"1996","journal-title":"AIDS"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB61","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2133.1985.tb02323.x","article-title":"Development of polyneuropathy during thalidomide therapy","volume":"112","author":"Wulff","year":"1985","journal-title":"Br J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB62","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/clinids\/21.4.981","article-title":"Old and new therapies for sporotrichosis","volume":"21","author":"Kauffman","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB63","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/myc.1990.33.5.231","article-title":"Sporotrichosis in the metropolitan area of Cusco, Peru, and in its region","volume":"33","author":"Cuadros","year":"1990","journal-title":"Mycoses"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB64","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2340\/0001555574217218","article-title":"Subcutaneous mucormycosis in a non-immunocompromised patient treated with potassium iodide","volume":"74","author":"Verma","year":"1994","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB65","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00006454-199604000-00014","article-title":"Treatment of cutaneous sporotrichosis with one daily dose of potassium iodide","volume":"15","author":"Cabezas","year":"1996","journal-title":"Pediatr Infect Dis"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0190-9622(83)70110-6","article-title":"Potassium iodide in erythema nodosum and other erythematous dermatoses","volume":"9","author":"Horio","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB67","first-page":"2461","article-title":"Erythema nodosum. Treatment with potassium iodide (letter)","volume":"12","author":"Heid","year":"1983","journal-title":"Presse Medicale"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB68","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archderm.117.1.29","article-title":"Potassium iodide in the treatment of erythema nodosum and nodular vasculitis","volume":"117","author":"Horio","year":"1981","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB69","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2133.1976.tb04345.x","article-title":"Treatment of erythema nodosum and nodular vasculitis with potassium iodide","volume":"94","author":"Schulz","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB70","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0190-9622(08)81516-2","article-title":"Potassium iodide in the treatment of disseminated granuloma annulare","volume":"30","author":"Smith","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB71","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/archderm.115.5.639","article-title":"Treatment of disseminated granuloma annulare with potassium iodide (letter)","volume":"115","author":"Giessel","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB72","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0190-9622(84)80228-5","article-title":"Treatment of granuloma annulare with potassium iodide (letter)","volume":"10","author":"Caserio","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB73","first-page":"124","article-title":"Potassium iodide in the treatment of sarcoidosis (letter)","volume":"124","author":"Graham","year":"1981","journal-title":"Can Med Assoc J"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB74","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0190-9622(08)80654-8","article-title":"Pyoderma gangrenosum treated successfully with potassium iodide","volume":"28","author":"Richardson","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB75","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0190-9622(96)90285-6","article-title":"Treatment of pyoderma gangrenosum","volume":"34","author":"Chow","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB76","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0190-9622(98)70039-8","article-title":"Cutaneous small-vessel vasculitis","volume":"39","author":"Lotti","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB77","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000247677","article-title":"Atypical neutrophilic dermatosis on the upper extremity affected by postmastectomy lymphedema","volume":"183","author":"Demitsu","year":"1991","journal-title":"Dermatologica"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB78","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2230.1987.tb02506.x","article-title":"Sweet\u2019s syndrome","volume":"12","author":"Myatt","year":"1987","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB79","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0307-742X(21)00394-5","article-title":"Sweet\u2019s syndrome (acute febrile neutrophilic dermatosis)","volume":"8","author":"Greer","year":"1982","journal-title":"Clin Rheumatol Dis"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB80","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-4362.1987.tb00887.x","article-title":"Sweet\u2019s syndrome","volume":"26","author":"Leibovici","year":"1987","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB81","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-4362.1993.tb04265.x","article-title":"Acute febrile neutrophilic dermatosis (Sweet\u2019s syndrome)","volume":"32","author":"Sitjas","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB82","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1155\/1997\/434989","article-title":"Successful therapy of refractory erythema nodosum associated with Crohn\u2019s disease using potassium iodide","volume":"11","author":"Marshall","year":"1997","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB83","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000250516","article-title":"Treatment of acute febrile neutrophilic dermatosis (Sweet\u2019s syndrome) with potassium iodide","volume":"160","author":"Horio","year":"1980","journal-title":"Dermtologica"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB84","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1525-1470.1996.tb01189.x","article-title":"Iododerma","volume":"13","author":"Alpay","year":"1996","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB85","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0190-9622(90)70057-O","article-title":"Vegetating iododerma with underlying systemic diseases","volume":"22","author":"Soria","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB86","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2133.1994.tb08481.x","article-title":"Triggering of bullous pemphigoid by iodine (letter)","volume":"13","author":"Piletta","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB87","doi-asserted-by":"crossref","first-page":"321","DOI":"10.7326\/0003-4819-122-5-199503010-00001","article-title":"Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma","volume":"122","author":"Moertel","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB88","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1200\/JCO.1991.9.5.729","article-title":"Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole","volume":"9","author":"Quirt","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB89","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00001622-199703000-00015","article-title":"Adjuvant therapy for melanoma","volume":"9","author":"Sondak","year":"1997","journal-title":"Curr Opin Oncol"},{"issue":"Suppl","key":"10.1016\/S0738-081X(99)00103-0_BIB90","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/1097-0142(19950115)75:2+<726::AID-CNCR2820751417>3.0.CO;2-R","article-title":"The role of adjuvant therapy in melanoma management","volume":"75(2","author":"Barth","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB91","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s004670050487","article-title":"Levamisole treatment in steroid-sensitive and steroid-resistant nephrotic syndrome","volume":"12","author":"Tenbrock","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB92","first-page":"51","article-title":"Levamisole in the treatment of crural ulcers","volume":"77","author":"Brzezinska-Wcislo","year":"1990","journal-title":"Przegl Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB93","first-page":"160","article-title":"Immunostimulation therapy in patients with alopecia areata","volume":"96","author":"Jautova","year":"1995","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB94","first-page":"60","article-title":"Generalized lichen nitidus in a child\u2019s response to cetirizine dihydrochloride\/levamisol (letter)","volume":"39","author":"Sehgal","year":"1998","journal-title":"Aust J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB95","first-page":"121","article-title":"Levamisole in chronic pyoderma","volume":"8","author":"Papageorgiou","year":"1982","journal-title":"J Clin Lab Immunol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB96","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00005792-198307000-00001","article-title":"The hyperimmunoglobulin E recurrent-infection (Job\u2019s) syndrome. A review of the NIH experience and the literature","volume":"62","author":"Donabedian","year":"1983","journal-title":"Medicine"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB97","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0190-9622(82)70092-1","article-title":"Levamisole and immune response phenomena in cutaneous leishmaniasis","volume":"6","author":"Butler","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB98","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-4362.1986.tb04520.x","article-title":"Oriental sore. A look at trends in and approaches to the treatment of leishmaniasis","volume":"25","author":"Chong","year":"1986","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB99","first-page":"221","article-title":"Levamisole therapy of chronic Leishmania tropica","volume":"81","author":"Butler","year":"1979","journal-title":"J Trop Med Hyg"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB100","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0738-081X(84)90070-1","article-title":"Treatment of mucocutaneous herpes simplex infection","volume":"2","author":"Seidlin","year":"1984","journal-title":"Clin Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB101","doi-asserted-by":"crossref","first-page":"390","DOI":"10.5694\/j.1326-5377.1980.tb131881.x","article-title":"Levamisole in patients with recurrent herpes infection","volume":"2","author":"Jose","year":"1980","journal-title":"Med J Aust"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB102","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000250483","article-title":"Levamisole plus indomethacin in the treatment of herpes simplex","volume":"160","author":"Hernandez-Perez","year":"1980","journal-title":"Dermatologica"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB103","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2340\/0001555564493500","article-title":"Clinical and immunological studies in chronic dermatophytosis caused by Trichophyton rubrum","volume":"64","author":"Svejgaard","year":"1984","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB104","first-page":"1160","article-title":"Levamisole treatment of acne fulminans","volume":"56","author":"Haneke","year":"1981","journal-title":"Z Hautkrank"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB105","first-page":"440","article-title":"Correlation between the immune reaction and clinical course in a bullous pemphigoid case treated with levamisole","volume":"2","author":"Carli-Basset","year":"1982","journal-title":"LARC Medical"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB106","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0030-4220(82)90212-2","article-title":"Pemphigus vulgaris. A study of six cases treated with levamisole and prednisone","volume":"54","author":"Lozada","year":"1982","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB107","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/art.1780240111","article-title":"Treatment of Behcet syndrome with levamisole","volume":"24","author":"de Metieux","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB108","first-page":"187","article-title":"Levamisole in systemic lupus erythematosus","volume":"43","author":"Ogawa","year":"1979","journal-title":"Ann Allergy"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB109","first-page":"45","article-title":"Levamisole as basic treatment of rheumatoid arthritis","volume":"8","author":"Veys","year":"1981","journal-title":"J Rheumatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB110","first-page":"61","article-title":"Levamisole (decaris) in the complex treatment of different clinical forms of psoriasis","volume":"4","author":"Liapon","year":"1984","journal-title":"Vestnik Dermatol Venereol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB111","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0738-081X(86)90036-2","article-title":"Cutaneous sarcoidosis","volume":"4","author":"Veien","year":"1986","journal-title":"Clin Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB112","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1001\/archderm.114.9.1314","article-title":"Levamisole therapy in atopic dermatitis","volume":"114","author":"White","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB113","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/infdis\/137.5.597","article-title":"A double-blind controlled trial of levamisole in the treatment of recurrent herpes labialis","volume":"137","author":"Russell","year":"1978","journal-title":"J Infect Dis"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB114","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-4362.1991.tb02624.x","article-title":"Verrucae treated by levamisole","volume":"30","author":"Amer","year":"1991","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB115","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-4362.1980.tb00355.x","article-title":"Treatment of multiple viral warts with levamisole","volume":"19","author":"Saul","year":"1980","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB116","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2340\/0001555557449454","article-title":"Levamisole in a double-blind study","volume":"57","author":"Schou","year":"1977","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB117","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1079-2104(05)80255-0","article-title":"Dramatic response to levamisole and low-dose prednisolone in 23 patients with oral lichen planus","volume":"80","author":"Lu","year":"1995","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endocl"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB118","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-4362.1994.tb02903.x","article-title":"Effect of prolonged treatment with levamisole on vitiligo with limited and slow-spreading disease","volume":"33","author":"Pasricha","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB119","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0030-4220(92)90062-U","article-title":"Clinical response to levamisole in thirty-nine patients with erythema multiforme. An open prospective study","volume":"74","author":"Lozada-Nur","year":"1992","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB120","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000248711","article-title":"Clofazimine-mediated enhancement of reactive oxidant production by human phagocytes as a possible therapeutic mechanism","volume":"176","author":"Anderson","year":"1988","journal-title":"Dermatologica"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB121","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-4362.1976.tb00672.x","article-title":"Clofazimine in dermatology","volume":"15","author":"Mackey","year":"1976","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB122","unstructured":"deCarsalade GY, Wallach D, Spindler E, et al. Daily multidrug therapy for leprosy: Results of a fourteen-year experience. Int J Leprosy Mycobact Dis 1997;65:37\u201344."},{"key":"10.1016\/S0738-081X(99)00103-0_BIB123","first-page":"11","article-title":"A comparative evaluation of levamisole in leprosy","volume":"57","author":"Sharma","year":"1985","journal-title":"Indian J Leprosy"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB124","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2340\/0001555563552553","article-title":"Pyoderma gangrenosum treated with clofazimine","volume":"63","author":"Rasmussen","year":"1983","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB125","first-page":"567","article-title":"Treatment of pyoderma gangrenosum with clofazimine. A case report and review of associated diseases","volume":"74","author":"Lovett","year":"1981","journal-title":"J Tenn Med Assoc"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB126","first-page":"232","volume":"177","author":"Mensing","year":"1988","journal-title":"Clofazimine in dermatitis ulcerosa (pyoderma gangrenosum). Open clinical trial. Dermatologica"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB127","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-4362.1992.tb02727.x","article-title":"Treatment of pyoderma gangrenosum with clofazimine","volume":"31","author":"Kaplan","year":"1992","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB128","first-page":"328","article-title":"Small bowel deposition of crystals associated with the use of clofazimine (Lamprene) in the treatment of prurigo nodularis","volume":"51","author":"Belaube","year":"1983","journal-title":"Int J Lep Mycobact Dis"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB129","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0307-742X(21)00394-5","article-title":"Sweet\u2019s syndrome (acute febrile neutrophilic dermatosis)","volume":"8","author":"Greer","year":"1982","journal-title":"Clin Rheumatol Dis"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB130","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1365-4362.1994.tb02924.x","article-title":"Erythema elevatum diutinum","volume":"33","author":"Farella","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB131","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1440-0960.1980.tb00162.x","article-title":"Further study of the use of clofazimine in discoid lupus erythematosus (letter)","volume":"21","author":"Krivanek","year":"1980","journal-title":"Aust J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB132","first-page":"99","article-title":"Clofazimine-therapeutic alternative in necrobiosis lipoidica and granuloma annulare","volume":"40","author":"Mensing","year":"1989","journal-title":"Hautarzt"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB133","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000247634","article-title":"Clofazimine for residual nodulocystic acne lesions (letter)","volume":"183","author":"Mascaro","year":"1991","journal-title":"Dermatologica"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB134","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000248737","article-title":"Cutaneous malakoplakia. Report of a case","volume":"176","author":"Palou","year":"1988","journal-title":"Dermatologica"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB135","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0190-9622(08)80708-6","article-title":"Successful treatment of a patient with cutaneous malacoplakia with clofazimine and trimethoprim-sulfamethoxazole","volume":"23","author":"Herrero","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB136","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2340\/00015555767779","article-title":"Clofazimine in inflammatory facial dermatosis\u2014granuloma faciale and lipogranulomatosis subcutanea (Rothmann-Makai) (letter)","volume":"76","author":"Wollina","year":"1996","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB137","first-page":"1207","article-title":"Eosinophilic pustular folliculitis (Ofuji\u2019s disease)","volume":"115","author":"Meissner","year":"1988","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB138","first-page":"505","article-title":"Impetigo herpetiformis\u2014a peculiar form of pustular psoriasis. Treatment with clofazimine and PUVA","volume":"68","author":"Rubisz-Brzezinska","year":"1981","journal-title":"Przegl Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB139","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-4362.1989.tb02466.x","article-title":"Clinical trial with clofazimine for treating erythema dyschromicum perstans. Evaluation of cell-mediated immunity","volume":"28","author":"Piquero-Martin","year":"1989","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB140","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/archderm.133.3.325","article-title":"Involvement of cell adhesion and activation molecules in the pathogenesis of erythema dyschromicum perstans (ashy dermatitis). The effect of clofazimine therapy","volume":"133","author":"Baranda","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB141","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000250155","article-title":"Evaluation of clofazimine in vitiligo","volume":"163","author":"Shukla","year":"1981","journal-title":"Dermatologica"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB142","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/clinids\/22.3.581-a","article-title":"Apparent exacerbation of vitiligo syndrome in a patient with pulmonary Mycobacterium avium complex disease who received clofazimine therapy","volume":"22","author":"Brown-Harrell","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB143","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-4362.1992.tb02727.x","article-title":"Treatment of pyoderma gangrenosum with clofazimine","volume":"31","author":"Kaplan","year":"1992","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB144","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archderm.115.7.851","article-title":"Clofazimine in the treatment of pyoderma gangrenosum","volume":"115","author":"Thomsen","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB145","first-page":"631","article-title":"Pyoderma gangrenosum","volume":"104","author":"Beurey","year":"1977","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB146","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.0954-6820.1977.tb15670.x","article-title":"Pyoderma gangrenosum associated with regional enteritis. Improvement in defective granulocyte function and healing of skin lesions during administration of clofazimine","volume":"201","author":"Brandt","year":"1977","journal-title":"Acta Med Scand"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB147","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0190-9622(81)70018-5","article-title":"Pyoderma gangrenosum treated with clofazimine. Report of three cases","volume":"4","author":"Kark","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB148","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-4362.1996.tb02981.x","article-title":"Malignant pyoderma","volume":"35","author":"Erdi","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB149","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000249403","article-title":"Malignant pyoderma. Report of a case associated with a disorder of the immune system","volume":"171","author":"Aram","year":"1985","journal-title":"Dermatologica"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB150","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2340\/0001555567535537","article-title":"Solid facial edema as a complication of acne vulgaris","volume":"67","author":"Helander","year":"1987","journal-title":"Acta Derma Venereol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB151","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s001050050187","article-title":"\u201cGranulomatous slack skin\u201d\u2014cutaneous elastolytic lymphoma","volume":"45","author":"von den Driesch","year":"1994","journal-title":"Hautarzt"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB152","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0733-8635(18)30636-3","article-title":"New drugs for dermatologic diseases","volume":"6","author":"Landow","year":"1988","journal-title":"Dermatol Clin"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB153","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2340\/000155555151153","article-title":"Clofazimine-enhanced phagocytosis in pustulosis palmaris et plantaris","volume":"55","author":"Molin","year":"1975","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB154","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2133.1978.tb02001.x","article-title":"Treatment of pustular psoriasis with clofazimine","volume":"99","author":"Chuaprapaisilp","year":"1978","journal-title":"Br J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB155","first-page":"63","article-title":"More about clofazimine\u20143 years\u2019 experience and review of literature","volume":"59","author":"Kumar","year":"1987","journal-title":"Indian J Leprosy"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB156","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0190-9622(90)70204-U","article-title":"Skin pigmentation from clofazimine therapy in leprosy patients","volume":"23","author":"Job","year":"1990","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/S0738-081X(99)00103-0_BIB157","first-page":"722","article-title":"Side effects of clofazimine therapy","volume":"48(4","author":"Ranu","year":"1976","journal-title":"Lepr India"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB158","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archderm.134.8.929","article-title":"Familial Mediterranean fever","volume":"134","author":"Muhn","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB159","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000441-199207000-00008","article-title":"Case report","volume":"304","author":"Lugassy","year":"1992","journal-title":"Am J Med Sci"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB160","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0049-0172(98)80028-0","article-title":"Colchicine","volume":"28","author":"Ben-Chetrit","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB161","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0190-9622(96)90013-4","article-title":"Colchicine for epidermolysis bullosa acquisita","volume":"34","author":"Cunningham","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB162","first-page":"301","article-title":"Value of colchicine in treating acquired epidermolysis bullosa","volume":"116","author":"Berbis","year":"1989","journal-title":"Ann Dermatol Venereo"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB163","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00375841","article-title":"Epidermolysis bullosa acquisita\u2014successful treatment with colchicine","volume":"286","author":"Megahed","year":"1994","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB164","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0190-9622(09)80120-5","article-title":"Successful treatment of chronic bullous dermatosis of childhood with colchicine","volume":"30","author":"Zeharia","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB165","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-4362.1997.00033.x","article-title":"Colchicine as a novel theapeutic agent in chronic bullous dermatosis of childhood","volume":"36","author":"Banodkar","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB166","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archderm.116.12.1373","article-title":"Treatment of dermatitis herpetiformis with colchicine","volume":"116","author":"Silvers","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB167","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1046\/j.1525-1470.1999.99015.x","article-title":"Treatment of linear IgA bullous dermatosis of childhood with colchicine","volume":"16","author":"Ang","year":"1999","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB168","first-page":"167","article-title":"Linear IgA disease\u2014a review of four patients","volume":"91","author":"Elling","year":"1998","journal-title":"Irish Med J"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB169","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0190-9622(99)70533-5","article-title":"Effect of colchicine in the subcorneal pustular dermatosis type of IgA pemphigus","volume":"40","author":"Hodak","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB170","first-page":"227","article-title":"Enhanced superoxide generation and the decreased superoxide scavenging activity of peripheral blood leukocytes in Behcet\u2019s disease\u2014effects of colchicine","volume":"9","author":"Pronai","year":"1991","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB171","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2165\/00003495-199142050-00006","article-title":"Practical treatment recommendations for pharmacotherapy of Behcet\u2019s syndrome","volume":"42","author":"Yazici","year":"1991","journal-title":"Drugs"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB172","first-page":"629","article-title":"Pustular vasculitis disclosing Behcet disease","volume":"121","author":"Castanet","year":"1994","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB173","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0190-9622(96)90006-7","article-title":"Behcet\u2019s disease. Report of twenty-five patients from the United States with prominent mucocutaneous involvement","volume":"34","author":"Mangelsdorf","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB174","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(89)92381-7","article-title":"Double-masked trial of cyclosporin versus colchicine and long-term open study to cyclosporin in Behcet\u2019s disease","volume":"1","author":"Masuda","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB175","unstructured":"Rampal P, Benzaken S, Schneider S, et al. Colchicine in pyoderma gangrenosum (letter). \u2022\u2022\u2022"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB176","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0190-9622(98)70275-0","article-title":"Colchicine in dermatology","volume":"39","author":"Sullivan","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB177","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00270458","article-title":"Colchicine treatment in a case of pachydermoperiostosis with acroosteolysis","volume":"8","author":"Matucci-Cerinic","year":"1988","journal-title":"Rheum Int"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB178","first-page":"527","article-title":"Colchicine suppression of local inflammation due to calcinosis in dermatomyositis and progressive systemic sclerosis","volume":"5","author":"Fuchs","year":"1986","journal-title":"Clin Rheumatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB179","first-page":"201","article-title":"Comparison of colchicine and aspirin in the treatment of type 2 lepra reaction","volume":"59","author":"Kar","year":"1988","journal-title":"Lepr Rev"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB180","first-page":"151","article-title":"Use of colchicine in the management of erythema nodosum leprosum","volume":"54","author":"Sarojini","year":"1983","journal-title":"Lepr Rev"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB181","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/ard.52.11.826","article-title":"Therapeutic value of colchicine in the treatment of patients with psoriatic arthritis","volume":"52","author":"McKendry","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB182","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2133.1989.tb04167.x","article-title":"Delayed pressure urticaria, objective evaluation of a variable disease using a dermographometer and assessment of treatment using colchicine","volume":"120","author":"Lawlor","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB183","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2230.1996.tb00160.x","article-title":"Acne conglobata","volume":"21","author":"Jeong","year":"1996","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB184","first-page":"95","article-title":"Colchicine treatment of abdominal pains in prophyric patients","volume":"25","author":"Wysenbeek","year":"1989","journal-title":"Israel J Med Sci"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB185","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-4362.1990.tb03804.x","article-title":"Bullous hemorrhagic primary systemic amyloidosis","volume":"29","author":"Pramatarov","year":"1990","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB186","first-page":"295","article-title":"Bullous amyloidosis","volume":"115","author":"Schmutz","year":"1988","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB187","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/ajcp\/92.6.821","article-title":"Amyloid goiter and arthritides after kidney transplantation in a patient with systemic amyloidosis and Muckle-Wells syndrome","volume":"92","author":"Schwarz","year":"1989","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB188","first-page":"310","article-title":"Chronic cutaneous vasculitis in a C3-deficient patient treated with colchicine","volume":"29","author":"Barash","year":"1993","journal-title":"Israel J Med Sci"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB189","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2230.1991.tb01227.x","article-title":"The normocomplementemic urticarial vasculitis syndrome\u2014report of a case and response to colchicine","volume":"16","author":"Asherson","year":"1991","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB190","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2230.1989.tb02611.x","article-title":"Erythema elevatum diutinum\u2014a case successfully treated with colchicine","volume":"14","author":"Henriksson","year":"1989","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB191","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archderm.131.12.1399","article-title":"Colchicine in the treatment of cutaneous leukocytoclastic vasculitis. Results of a prospective, randomized controlled trial","volume":"131","author":"Sais","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB192","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2340\/0001555560515520","article-title":"Therapeutic trials with oral colchicine in psoriasis","volume":"60","author":"Wahba","year":"1980","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB193","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/archderm.118.7.453","article-title":"Colchicine. New uses of an old, old drug","volume":"118","author":"Malkinson","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB194","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF00403737","article-title":"Colchicine in generalized pustular psoriasis","volume":"274","author":"Zachariae","year":"1982","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB195","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archderm.118.7.458","article-title":"Treatment of pustulosis palmaris et plantaris with oral doses of colchicine","volume":"118","author":"Takigawa","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB196","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2340\/00015555647678","article-title":"Treatment of pustulosis palmaris et plantaris with colchicine. A double-blind cross-over trial","volume":"64","author":"Thestrup-Pedersen","year":"1984","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB197","first-page":"777","article-title":"Psoriatic arthritis treated with oral colchicine","volume":"14","author":"Seideman","year":"1987","journal-title":"J Rheumatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB198","first-page":"705","article-title":"Long-term evaluation of colchicine in the treatment of scleroderma","volume":"6","author":"Alarcon-Segovia","year":"1979","journal-title":"J Rheumatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB199","first-page":"272","article-title":"Colchicine in the treatment of scleroderma","volume":"4","author":"Guttadauria","year":"1977","journal-title":"J Rheumatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB200","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/ard.50.Suppl_4.877","article-title":"Treatment of systemic sclerosis","volume":"50","author":"Medsger","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB201","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0190-9622(98)70175-6","article-title":"Treatment of primary anetoderma with colchicine","volume":"38","author":"Braun","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB202","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2340\/00015555608789","article-title":"Topical treatment of penile condylomata acuminata with colchicine at 48\u201372-hour intervals","volume":"60","author":"von Krogh","year":"1980","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB203","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2340\/0001555558163168","article-title":"Topical treatment of penile condylomata acuminata with podophyllin, podophyllotoxin and colchicine. A comparative study","volume":"58","author":"von Krogh","year":"1978","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB204","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0168-8278(98)80071-8","article-title":"Wilson\u2019s disease before and after 5 years of treatment with d-penicillamine","volume":"29","author":"Zachoval","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB205","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1212\/WNL.44.6.1079","article-title":"Treatment with d-penicillamine improves dopamine D2-receptor binding and T2-signal intensity in de novo Wilson\u2019s disease","volume":"44","author":"Schwarz","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB206","doi-asserted-by":"crossref","first-page":"720","DOI":"10.7326\/0003-4819-115-9-720","article-title":"Wilson disease","volume":"115","author":"Stremmel","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB207","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJM199006283222615","article-title":"Use of penicillamine in children with small lead burdens (letter)","volume":"322","author":"Anonymous","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB208","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/ard.53.12.812","article-title":"Outcome of second-line therapy in rheumatoid arthritis","volume":"53","author":"Porter","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB209","first-page":"815","article-title":"The HS, et al","volume":"18","author":"van Rijthoven","year":"1991","journal-title":"Comparison of cyclosporine and d-penicillamine for rheumatoid arthritis: A randomized, double-blind, multicenter study. J Rheumatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB210","first-page":"625","article-title":"d-Penicillamine in early rheumatoid arthritis","volume":"14","author":"Eberhardt","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB211","first-page":"160","article-title":"Combination d-penicillamine and methotrexate therapy","volume":"50","author":"Lee","year":"1990","journal-title":"Bull Hosp Jt Dis Orthop Instit"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB212","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/rheumatology\/32.7.614","article-title":"The long-term use of d-penicillamine for treating rheumatoid arthritis","volume":"32","author":"Doyle","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB213","first-page":"621","volume":"147","author":"Nadal","year":"1988","journal-title":"Menkes\u2019 disease long-term treatment with copper and d-penicillamine Eur J Pediatr"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB214","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1525-1470.1993.tb00061.x","article-title":"Treatment of childhood linear norphea with d-penicillamine (letter)","volume":"10","author":"Kaur","year":"1993","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB215","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0049-0172(05)80024-1","article-title":"Outcome measurement in scleroderma clinical trials","volume":"23","author":"Pope","year":"1993","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB216","first-page":"1496","article-title":"A 15-year prospective study of treatment of rapidly progressive systemic sclerosis with d-penicillamine","volume":"18","author":"Jimenez","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB217","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/BF02030514","article-title":"Penicillamine in systemic sclerosis","volume":"9","author":"Sattar","year":"1990","journal-title":"Clin Rheumatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB218","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1085-5629(98)80063-1","article-title":"Management of systemic sclerosis","volume":"17","author":"Stone","year":"1998","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB219","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7","article-title":"High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis","volume":"42","author":"Clements","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB220","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0889-857X(05)70307-0","article-title":"Treatment of systemic sclerosis","volume":"22","author":"Pope","year":"1996","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB221","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O","article-title":"Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis","volume":"41","author":"Steen","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB222","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archderm.126.5.609","article-title":"d-penicillamine in the treatment of localized scleroderma","volume":"126","author":"Falanga","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB223","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/ard.46.3.177","article-title":"Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine","volume":"46","author":"Situnayake","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB224","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/rheumatology\/28.1.53","article-title":"The effect of continuing penicillamine and gold treatment on the course of penicillamine and gold nephropathy","volume":"28","author":"Hall","year":"1989","journal-title":"Br J Rheumatol"},{"key":"10.1016\/S0738-081X(99)00103-0_BIB225","unstructured":"Hippocrates (460\u2013377 bc). On Joints, 78."}],"container-title":["Clinics in Dermatology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X99001030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X99001030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T23:49:35Z","timestamp":1703980175000},"score":17.534199,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X99001030"}},"issued":{"date-parts":[[2000,1]]},"references-count":225,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["S0738081X99001030"],"URL":"https:\/\/doi.org\/10.1016\/s0738-081x(99)00103-0","ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"published":{"date-parts":[[2000,1]]}},{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:06:27Z","timestamp":1725840387836},"publisher-location":"London","reference-count":0,"publisher":"Macmillan Education UK","isbn-type":[{"type":"print","value":"9780333492420"},{"type":"electronic","value":"9781349108725"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[1988]]},"DOI":"10.1007\/978-1-349-10872-5_6","type":"book-chapter","created":{"date-parts":[[2015,12,4]],"date-time":"2015-12-04T04:26:58Z","timestamp":1449203218000},"page":"123-188","source":"Crossref","is-referenced-by-count":0,"title":["Miscellaneous and Empirical Treatments"],"prefix":"10.1007","author":[{"name":"Therapeutic Claims Committee of the International Federation of Multiple Sclerosis Societies","sequence":"first","affiliation":[]},{"given":"William A.","family":"Sibley","sequence":"first","affiliation":[]}],"member":"297","container-title":["Therapeutic Claims in Multiple Sclerosis"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-349-10872-5_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,12,4]],"date-time":"2015-12-04T04:27:00Z","timestamp":1449203220000},"score":17.488956,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-349-10872-5_6"}},"issued":{"date-parts":[[1988]]},"ISBN":["9780333492420","9781349108725"],"references-count":0,"URL":"https:\/\/doi.org\/10.1007\/978-1-349-10872-5_6","published":{"date-parts":[[1988]]}},{"indexed":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T02:13:31Z","timestamp":1714443211201},"reference-count":0,"publisher":"Elsevier","isbn-type":[{"value":"9780080970639","type":"print"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2011]]},"DOI":"10.1016\/b978-0-08-097063-9.10017-2","type":"book-chapter","created":{"date-parts":[[2011,4,14]],"date-time":"2011-04-14T21:44:46Z","timestamp":1302817486000},"page":"311-327","source":"Crossref","is-referenced-by-count":1,"title":["Miscellaneous Systems"],"prefix":"10.1016","author":[{"given":"Ian","family":"Sinclair","sequence":"first","affiliation":[]}],"member":"78","container-title":["Electronics Simplified"],"language":"en","deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T16:21:28Z","timestamp":1543854088000},"score":17.424929,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780080970639100172"}},"issued":{"date-parts":[[2011]]},"ISBN":["9780080970639"],"references-count":0,"URL":"https:\/\/doi.org\/10.1016\/b978-0-08-097063-9.10017-2","published":{"date-parts":[[2011]]}},{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T21:12:33Z","timestamp":1694639553410},"edition-number":"1","reference-count":0,"publisher":"Cambridge University Press","isbn-type":[{"value":"9780521878180","type":"print"},{"value":"9780511676062","type":"electronic"}],"license":[{"start":{"date-parts":[[2010,5,18]],"date-time":"2010-05-18T00:00:00Z","timestamp":1274140800000},"content-version":"unspecified","delay-in-days":120,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2010,1,18]]},"DOI":"10.1017\/cbo9780511676062.010","type":"book-chapter","created":{"date-parts":[[2010,6,2]],"date-time":"2010-06-02T14:47:58Z","timestamp":1275490078000},"page":"309-359","source":"Crossref","is-referenced-by-count":0,"title":["Miscellaneous Systems"],"prefix":"10.1017","member":"56","container-title":["Numerical Notation"],"link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/21A6600FF10D7F00F173D55A0286C836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T03:29:45Z","timestamp":1654918185000},"score":17.306808,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/CBO9780511676062A015\/type\/book_part"}},"issued":{"date-parts":[[2010,1,18]]},"ISBN":["9780521878180","9780511676062"],"references-count":0,"URL":"https:\/\/doi.org\/10.1017\/cbo9780511676062.010","published":{"date-parts":[[2010,1,18]]}},{"indexed":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T03:39:49Z","timestamp":1726025989483},"edition-number":"0","reference-count":1,"publisher":"CRC Press","isbn-type":[{"type":"electronic","value":"9780429130694"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2011,4,25]]},"DOI":"10.1201\/b10846-11","type":"book-chapter","created":{"date-parts":[[2011,7,20]],"date-time":"2011-07-20T19:19:54Z","timestamp":1311189594000},"page":"391-468","source":"Crossref","is-referenced-by-count":0,"title":["Miscellaneous Forms of Drug Delivery"],"prefix":"10.1201","member":"301","reference":[{"key":"ref8","unstructured":"1. Yalkowsky, S.H. and Morozowich, W., Drug Design, Vol. 9, Ariens Academic Press, Inc., New York, 1980."}],"container-title":["Drug Delivery Systems"],"language":"en","link":[{"URL":"http:\/\/www.crcnetbase.com\/doi\/pdf\/10.1201\/b10846-11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T23:47:48Z","timestamp":1614988068000},"score":17.30146,"resource":{"primary":{"URL":"https:\/\/www.taylorfrancis.com\/books\/9781439806197\/chapters\/10.1201\/b10846-11"}},"issued":{"date-parts":[[2011,4,25]]},"ISBN":["9780429130694"],"references-count":1,"URL":"https:\/\/doi.org\/10.1201\/b10846-11","published":{"date-parts":[[2011,4,25]]}}],"items-per-page":20,"query":{"start-index":0,"search-terms":"Miscellaneous+systems+and+treatments"}}}